IL1B and COVID-19: During SARS-CoV-2 infection, activation of the NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome pathway is thought to contribute to the release of bioactive IL-1β and IL-18, cytokines associated with severe COVID-19 [6, 7, 36, 37].